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minimal reduction of HCVRNA synthesis, suggesting that inhibition of
replication is not due to a direct suppression of replicase activity.
Conclusions: The intracellular expression of antibodies that target HCV
proteins and inhibit important viral functions may represent a promising
new direction for therapy of HCV infection.
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Background and Aims: Chronic hepatitis C (CHC) has been associated
with type 2 diabetes and insulin resistance. A crucial role of inflammatory
cytokines in the pathogenesis of the HCV-associated insulin resistance state
has been suggested. This study was undertaken to explore the relationship
between liver expression of inflammatory mediators and hepatic insulin
resistance in a group of lean, non-diabetic CHC patients.
Methods: We performed a euglycaemic hyperinsulinaemic clamp
(1mU·min−1·kg−1) coupled with tracer infusion ([6,6-2H2glucose) in 10
lean, non-diabetic patients with biopsy-proven CHC, and in 7 matched
healthy controls. We also measured the gene expression of tumor necrosis
factor-alpha (TNF-alpha), interleukin-18 (IL-18) and suppressor of cy-
tokine signaling 3 (SOCS3) in liver biopsies by quantitative PCR and
tested their association with the metabolic parameters.
Results: Compared to controls, in CHC patients basal endogenous glucose
production (EGP) was 20% higher (p = 0.011) and its suppression during
the clamp (hepatic insulin sensitivity) was markedly reduced (p = 0.007),
resulting in a 3.5-fold higher EGP. Patients had an increased hepatic ex-
pression of TNF-alpha (median, 5.7 fold increase; range 2−10 fold), IL-18
(median, 5.7 fold increase; range 3−11 fold) and SOCS3 (median, 0.84
fold increase; range 0.5−1.2 fold). Notably, in CHC a decreased insulin-
stimulated suppression of EGP was associated with increased hepatic IL-18
(r = 0.63, p< 0.05) and SOCS3 expression (r = 0.68, p< 0.05), whereas the
hepatic expression of TNF-alpha showed only a positive trend (p = 0.09).
Conclusions: Hepatitis C infection per se is associated with hepatic insulin
resistance. Increased hepatic expression of SOCS3 and IL-18 is associated
with defective glucose regulation in the liver.
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Background and Aims: Hepatitis C virus (HCV) infects an estimated
3% of the world’s population, of all individuals infected with HCV,
85% develop persistent infections. Anti-HCV Drug is in need urgently
worldwide. Fel. Ursi, one of traditional Chinese drug originated from
animal, has been used for treating Hepatitis C related syndrome for about
3000 years, it is still in work clinically.There is potentiality to create a HCV
protease inhibitor based on the proved clinical experiences of Chinese
medicine.
Method: The activity of HCV NS3/4A Protease was detected by Sen-
soLyteTM520 HCV Protease Assay Kit. The active constituents were
obtained by bioactivity-guided separation with Silica gel, ODS, Sephadex
column chromatography and preparative HPLC, coupled with membrane
filter and enzymolysis, they were identified by MS and NMR spectrum
etc.
Result: The water solution of Fel Ursi inhibited the activity of HCV
NS3/4A Protease in a dose-depended manner with an IC50 of 0.3mg/ml;
all of the small molecular compounds isolated from Fel Ursi powder, which
were identified as bile acids including TUDCA and TCDCA, possessed
less than 40% of inhibiting activity at the concentration of 100 mg/ml,
all individuals, as well as the mixture of them, were not as effective as
Fel Ursi powder. However the larger molecule constituents, the rejection
of Fel Ursi water solution by 100K membrane filter, had shown higher
inhibiting activity than 90% at 100mg/ml, the activity was reduced to
less than 10% by enzymolysis only with proteinase, the rejection with
more 100000 molecule weight was proposed active proteins. By further
separation with Sephadex G100, 4 fraction with different molecule weight
were collected, F01 is the largest molecule fraction in the rejection which
has been named BBP100K01, it is the most effective protein with more
than 95% of inhibiting activity at 100 mg/ml, which activity is much better
than that of Fel Ursi powder.
Conclusion: Both Fel Ursi and BBP100K01 is effective HCV NS3/4A
protease inhibitor. Fel Ursi may show expected effect for Hepatitis C
clinically, BBP100K01 is a promising drug lead of anti-HCV. Traditional
wisdom in clinical practice can be a super modern solution for hepatitis C.
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Background and Aims: The hepatitis C virus (HCV) non-structural (NS)
4B protein initiates the membranous web formation at the Endoplasmatic
reticulum (ER) which is assumed to represent the viral replication complex.
The exact mechanisms of this process are unknown, but interactions of
NS4B with other proteins seem likely. We recently identified a basic
leucine zipper (bZIP) motif within the aminoterminal part of NS4B
and showed a high degree of amino acid conservation. The bZIP is
a protein structure motif facilitating protein-protein interactions. Here,
we investigated the HCV NS4B bZIP motif for possible protein-protein
interactions including NS4B homodimerization.
Methods: We applied a pcDNA3−1(-) vector expression plasmid con-
taining the complete HCV NS4B sequence. Different tags were imple-
mented by multiple site-directed mutagenesis. Mutagenesis experiments
of the bZIP motif were based on in-silico sequence analysis and a
subsequent “charged-to-alanine” transfer at crucial aa positions. Protein
expression of native and modified NS4B was investigated by Western blot
analysis. Interaction with putative binding partners was studied by co-
immunoprecipitation. Comparative structure-modelling and molecular dy-
namics simulations were applied to investigate the NS4B protein structure
and homodimerization.
Results: Successful expression of NS4B plasmids containing wildtype
and modified bZIP motifs alone and together was proven by Western
blot. Interaction between different wildtype NS4B protein molecules was
shown by co-immunoprecipitation. This interaction was undetectable with
NS4B proteins containing the modified bZIP sequence. A weak interaction
was seen when only one partner contained the mutated bZIP motif. We
modelled the three-dimensional structure of a NS4B homodimer and ana-
lyzed the molecular mechanisms of protein-protein interaction. Molecular
dynamics simulation was used to assess the binding affinities for wildtype
and mutant NS4B dimers.
Interaction energies calculated upon energy minimization and molecular
dynamics simulations were
